{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:57:04Z","timestamp":1792659424602,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.cmi.2021.06.036","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T06:07:00Z","timestamp":1625638020000},"page":"1652-1657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":280,"title":["BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-2032","authenticated-orcid":false,"given":"Tal","family":"Brosh-Nissimov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrat","family":"Orenbuch-Harroch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Chowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meital","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Nesher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Maor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regev","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khetam","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Zimhony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibiana","family":"Chazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronza","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Zayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Rahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonit","family":"Wiener-Well","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2021.06.036_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.06.036_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.06.036_bib4","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.06.036_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Nationwide vaccination campaign with BNT162b2 in Israel demonstrates high vaccine effectiveness and marked declines in incidence of SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2021.06.036_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01337-2","article-title":"COVID-19 dynamics after a national immunization program in Israel","author":"Rossman","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cmi.2021.06.036_bib7","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2110475","article-title":"Correspondence: BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","author":"Barda","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.06.036_bib8","article-title":"Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged \u2265 65 years\u2014United States, January\u2013March 2021","volume":"70","author":"Tenforde","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2021.06.036_bib9","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/S0140-6736(21)00677-2","article-title":"Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study","volume":"397","author":"Vasileiou","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2021.06.036_bib10","article-title":"Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England","author":"Bernal","year":"2021","journal-title":"MedRxiv"},{"key":"10.1016\/j.cmi.2021.06.036_bib11","article-title":"Reduced humoral response to mRNA SARS-Cov-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus","author":"Grupper","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2021.06.036_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","author":"Rabinowich","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2021.06.036_bib13","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","author":"Herishanu","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cmi.2021.06.036_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfab155","article-title":"Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients\u2014a prospectivecohort study","author":"Agur","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cmi.2021.06.036_bib15","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.03500321","article-title":"Humoral response to the Pfizer BNT162b2 vaccine in patients undergoing maintenance hemodialysis","volume":"16","author":"Grupper","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2021.06.036_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S2213-2600(20)30316-7","article-title":"Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study","volume":"8","author":"Karagiannidis","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2021.06.036_bib18","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1001\/jama.2020.7202","article-title":"Characteristics of hospitalized adults with COVID-19 in an integrated health care system in California","volume":"323","author":"Myers","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2021.06.036_bib19","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2021.06.036_bib20","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2021.06.036_bib21","author":"Diasorin"},{"key":"10.1016\/j.cmi.2021.06.036_bib22","article-title":"SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area","author":"Ng","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.cmi.2021.06.036_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/vaccines9030243","article-title":"Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2\/COVID-19","volume":"9","author":"G\u00f3mez","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.cmi.2021.06.036_bib24","volume":"3","author":"Novavax","year":"2021"},{"key":"10.1016\/j.cmi.2021.06.036_bib25","article-title":"Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals","author":"Kustin","year":"2021","journal-title":"MedRxiv"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21003670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21003670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:29:22Z","timestamp":1761118162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X21003670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1198743X21003670"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2021.06.036","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2021.06.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}